Canada Markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.74-0.59 (-1.72%)
At close: 4:00PM EDT

33.69 -0.05 (-0.14%)
After hours: 4:01PM EDT

Currency in USD

Valuation Measures

Market Cap (intraday) 51.26B
Enterprise Value 31.01B
Trailing P/E N/A
Forward P/E 1-16.87
PEG Ratio (5 yr expected) 1-6.10
Price/Sales (ttm)24.17
Price/Book (mrq)2.99
Enterprise Value/Revenue 319.42
Enterprise Value/EBITDA 6-7.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 3-14.28%
S&P500 52-Week Change 3N/A
52 Week High 354.97
52 Week Low 320.03
50-Day Moving Average 337.15
200-Day Moving Average 338.76

Share Statistics

Avg Vol (3 month) 3384k
Avg Vol (10 day) 3298.07k
Shares Outstanding 537.19M
Float 27.15M
% Held by Insiders 114.83%
% Held by Institutions 192.37%
Shares Short (Jul. 14, 2020) 44.39M
Short Ratio (Jul. 14, 2020) 411.32
Short % of Float (Jul. 14, 2020) 418.71%
Short % of Shares Outstanding (Jul. 14, 2020) 411.78%
Shares Short (prior month Jun. 14, 2020) 44.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin -197.23%
Operating Margin (ttm)-290.02%

Management Effectiveness

Return on Assets (ttm)-19.18%
Return on Equity (ttm)-22.61%

Income Statement

Revenue (ttm)51.99M
Revenue Per Share (ttm)1.41
Quarterly Revenue Growth (yoy)1,895.90%
Gross Profit (ttm)-97.19M
EBITDA -143.26M
Net Income Avi to Common (ttm)-102.54M
Diluted EPS (ttm)-2.78
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)279.26M
Total Cash Per Share (mrq)7.5
Total Debt (mrq)10.44M
Total Debt/Equity (mrq)2.49
Current Ratio (mrq)10.64
Book Value Per Share (mrq)11.30

Cash Flow Statement

Operating Cash Flow (ttm)-113.98M
Levered Free Cash Flow (ttm)-101.43M